Reaction Details Report a problem with these data
Target
Tyrosine-protein kinase JAK2 [828-1132]
Ligand
BDBM246853
Substrate
n/a
Meas. Tech.
In Vitro JAK Kinase Assay
IC50
650±n/a nM
Citation
 Li, Y; Zhuo, J; Qian, D; Mei, S Bipyrazole derivatives as JAK inhibitors US Patent  US10435392 Publication Date 10/8/2019 
Target
Name:
Tyrosine-protein kinase JAK2 [828-1132]
Synonyms:
JAK2 | JAK2 (aa 828-1132) | JAK2_HUMAN | Tyrosine-protein kinase JAK2
Type:
n/a
Mol. Mass.:
35579.28
Organism:
Homo sapiens (Human)
Description:
O60674[828-1132]
Residue:
305
Sequence:
GALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG
  
Inhibitor
Name:
BDBM246853
Synonyms:
4-[3-(cyanomethyl)- 3-(3',5'-dimethyl- 1H,1'H-4,4'- bipyrazol-1- yl)azetidin-1-yl]-2,5- difluoro-N-[(1S)- 2,2,2-trifluoro-1- methylethyl] benzamide | US10053465, 2 | US10065963, Compound 2 | US10125150, Example 2 | US10336759, # 2 | US10435392, Example 17 | US10479803, Example 2D | US10519163, Example 2 | US10675284, Example 2 | US11084822, Example 2 | US11130767, # 2 | US11136326, Example 2 | US11304949, Compound 4 | US11324749, Comp. No. 4 | US11591318, Example 7 | US11596632, Comp. No. 4 | US20240058343, Compound 4 | US9732097, Example 2 | US9926301, Example 17
Type:
Small organic molecule
Emp. Form.:
C23H22F5N7O
Mol. Mass.:
507.4591
SMILES:
C[C@H](NC(=O)c1cc(F)c(cc1F)N1CC(CC#N)(C1)n1cc(cn1)-c1c(C)n[nH]c1C)C(F)(F)F |r|
Structure:
Search PDB for entries with ligand similarity: